Defining the role of SGAs in the long-term treatment of bipolar disorder

Bipolar Disorders

Volumn 19, Issue 1, 2017, Pages 65-67

  Malhi, Gin S ^a,b,c   Morris, Grace ^a,b,c   Hamilton, Amber ^a,b,c   Outhred, Tim ^a,b,c   Das, Pritha ^a,b,c  

^a St George Hospital and Community Health Service   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

bipolar disorder; maintenance treatment; second generation antipsychotics

Indexed keywords

ANTICONVULSIVE AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; SECOND GENERATION ANTIPSYCHOTIC AGENT; UNCLASSIFIED DRUG;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; COMBINATION CHEMOTHERAPY; DEPRESSION; DISEASE SEVERITY; DRUG COST; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MAINTENANCE THERAPY; MANIA; MOOD; NOTE; PHASE TRANSITION; PRACTICE GUIDELINE; RECURRENT DISEASE; RELAPSE; REMISSION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; HUMANS; LONG-TERM CARE;

EID: 85016211572     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12472     Document Type: Note

References (5)

1. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15:1-44.
2. Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust NZ J Psychiatry. 2015;49:1087-1206.
3. Tohen M, Chengappa RK, Suppes T, et al. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry. 2004;184:337-345.
4. Yatham L, Beaulieu S, Schaffer A, et al. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: a CANMAT randomized double-blind trial. Mol Psychiatry. 2016;21:1050-1056.
5. Bartoli F, Dell'Osso B, Crocamo C, et al. Benefits and harms of low and high second-generation antipsychotics doses for bipolar depression: a meta-analysis. J Psychiatr Res. 2017;88:38-46.